Crossject is revolutionizing needle free injection

Paragraphes

Crossject is revolutionizing the administration of well-established treatments with its needle-free auto-injector ZENEO®. The prefilled, single-use device propels the medicine through the skin in less than a tenth of a second. Crossject currently has seven solutions in advanced stages of development, six of which are for emergency situations.  

Zeneo illustration

 

Our news

Image de l'actualité

Injecta Summit - June 27-28, 2024 -Barcelona

Résumé de l'actualité

Henri Bodeau, Business Development Manager, will be Keynote Speaker at the Summit

Image de l'actualité

CPhI North America

Résumé de l'actualité

May 7-9, 2024,  Philadelphia